跳至主要内容
临床试验/KCT0000078
KCT0000078撤回未知

Short term Pretreatment with Atorvastatin for Reduction of early recurrence of Tachyarrhythmias after cather Ablation for Atrial Fibrillation (SPARTA-AF)

Koera University Guro Hospital0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
撤回
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1) Age >= 18
  • 2) Subject with atrial fibrillation that is indicated to radiofrequency catheter ablation
  • 3) Radiofrequency catheter ablation must be able to perform
  • 4) Subject who able to take antiplatelet agent (aspirin, clopidogel), anticoagulant agent (warfarin) and antiarrhythmic agent for more than one year
  • 5) Subject who give written consent to this study

排除标准

  • 1) Subject with intracardiac thrombus
  • 2) Uncontrolled hypertension
  • 3) Chronic kidney disease (serum creatinine > 2.0 mg/dl)
  • 4) Chronic alcoholics, severe hepatosis (more than three-fold of upper normal range)
  • 5) Subject who is taking prohibited combination drug with atorvastatin (intraconazole, ketoconazole etc.)
  • 6) Chronic obstructive pulmonary disease
  • 7) Significant valvular heart disease
  • 8) History of coagulopathy
  • 9) Chronic heart failure
  • 10) Previous history of radiofrequency catheter ablation
  • 11) Pregnancy
  • 12) Hypersensitibity to contrast
  • 13) Life expectancy under one year due to the other diseases

研究者

发起方
Koera University Guro Hospital

相似试验

进行中(未招募)
1 期
TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis - TRACE RARheumatoid arthritis is associated with increased mortality from cardiovascular disease (CVD). Statins have a proven effect in reducing CVD events in at-risk populations, mostly due to their cholesterol-lowering properties, but possibly through anti-inflammatory and immunomodulatory effects. This trial will assess the hypothesis that atorvastatin is more effective than placebo in the primary prevention of cardiovascular events in patients with RA.
EUCTR2006-006032-22-GBniversity of Manchester5,350
已完成
不适用
Effects of Atorvastatin on Hepatitis B vaccination efficacyImmunization against Viral Hepatitis B.Need for immunization against Viral Hepatitis
IRCT201109147556N1Baqiyatallah University of Medical Sciences52
进行中(未招募)
1 期
Reduction of prostate cancer growth with cholesterol-lowering atorvastatin drugMedDRA version: 14.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate cancer
EUCTR2011-005438-20-FIniversity of Tampere160
招募中
不适用
Pharmacological intervention of Atorvastatin vs. Rosvastatin in patients with acute Ischemic Stroke (ARIS study)Hypercholesterolemia coupled with ischemic stroke
JPRN-UMIN000004608Department of Stroke Treatment,Shonan Kamakura General Hospital50
已完成
4 期
Pharmacological intervention of Atorvastatin vs. Rosvastatin in patients with Acute coronary Syndrome (ATRAS study)Coronary Artery Disease
JPRN-UMIN000004200Division of cardiology, Department of Internal Medicine, Memorial Heart Center, Iwate Medical University100